| SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden AS Rudberg, S Havervall, A Månberg, A Jernbom Falk, K Aguilera, H Ng, ... Nature communications 11 (1), 5064, 2020 | 325 | 2020 |
| Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID‐19 S Havervall, H Ng, A Jernbom Falk, N Greilert‐Norin, A Månberg, ... Journal of internal medicine 291 (1), 72-80, 2022 | 59 | 2022 |
| SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection S Havervall, A Jernbom Falk, J Klingström, H Ng, N Greilert-Norin, ... PloS One 17 (1), e0262169, 2022 | 43 | 2022 |
| Array-based profiling of proteins and autoantibody repertoires in CSF E Pin, R Sjöberg, E Andersson, C Hellström, J Olofsson, A Jernbom Falk, ... Cerebrospinal fluid (CSF) proteomics: methods and protocols, 303-318, 2019 | 33 | 2019 |
| Systematic evaluation of SARS‐CoV‐2 antigens enables a highly specific and sensitive multiplex serological COVID‐19 assay S Hober, C Hellström, J Olofsson, E Andersson, S Bergström, ... Clinical & Translational Immunology 10 (7), e1312, 2021 | 30 | 2021 |
| Multiomics profiling of Alzheimer’s disease serum for the identification of autoantibody biomarkers P San Segundo-Acosta, A Montero-Calle, A Jernbom-Falk, ... Journal of Proteome Research 20 (11), 5115-5130, 2021 | 21 | 2021 |
| Autoantibody profiles associated with clinical features in psychotic disorders A Jernbom Falk, C Galletly, D Just, C Toben, BT Baune, SR Clark, D Liu, ... Translational Psychiatry 11 (1), 474, 2021 | 16 | 2021 |
| An evaluation of a FluoroSpot assay as a diagnostic tool to determine SARS-CoV-2 specific T cell responses SM Mangsbo, S Havervall, I Laurén, R Lindsay, A Jernbom Falk, ... PLoS One 16 (9), e0258041, 2021 | 12 | 2021 |
| Antibodies to SARS-CoV-2 and risk of past or future sick leave J Dillner, KM Elfström, J Blomqvist, C Eklund, C Lagheden, ... Scientific Reports 11 (1), 5160, 2021 | 11 | 2021 |
| SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden. Nat Commun. 2020; 11 (1): 5064 AS Rudberg, S Havervall, A Månberg, A Jernbom Falk, K Aguilera, H Ng, ... Epub 2020/10/10. https://doi. org/10.1038/s41467-020-18848-0 PMID: 33033249, 0 | 11 | |
| SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden. Nat Commun 2020; 11: 5064 AS Rudberg, S Havervall, A Månberg, A Jernbom Falk, K Aguilera, H Ng, ... | 10 | |
| High amounts of SARS-CoV-2 precede sickness among asymptomatic health care workers J Dillner, KM Elfström, J Blomqvist, L Engstrand, M Uhlén, C Eklund, ... The Journal of Infectious Diseases 224 (1), 14-20, 2021 | 7 | 2021 |
| Comparative serum proteomic analysis of a selected protein panel in individuals with schizophrenia and bipolar disorder and the impact of genetic risk burden on serum proteomic … M Oraki Kohshour, NR Kannaiyan, AJ Falk, S Papiol, U Heilbronner, ... Translational Psychiatry 12 (1), 471, 2022 | 2 | 2022 |
| Prevalent and persistent new-onset autoantibodies in mild to severe COVID-19 A Jernbom Falk, L Skoglund, E Pin, R Sjöberg, H Tegel, S Hober, ... medRxiv, 2024.02. 15.24302857, 2024 | | 2024 |
| On the analysis of antibody repertoires A Jernbom Falk KTH Royal Institute of Technology, 2023 | | 2023 |
| BEYOND NEURORECEPTOR AUTOIMMUNITY: PERIPHERAL AUTOANTIBODY PROFILES ARE ASSOCIATED WITH CLINICAL FEATURES IN PSYCHOTIC DISORDERS A Jernbom Falk, C Galletly, D Just, C Toben, BT Baune, SR Clark, D Liu, ... Australian and New Zealand journal of psychiatry (Print) 56 (1_SUPPL), 90-91, 2022 | | 2022 |
Peter NilssonSciLifeLab (Science for Life Laboratory), Dept Protein Science, KTH Royal Institute of TechnologyVerified email at scilifelab.se
